DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,004 | -1.9% | 93,800 | +64.3% | 0.00% | – |
| Q2 2023 | $246,672 | +181.9% | 57,100 | -0.2% | 0.00% | – |
| Q1 2023 | $87,498 | +0.3% | 57,188 | +3.6% | 0.00% | – |
| Q4 2022 | $87,223 | +32.2% | 55,201 | +4.1% | 0.00% | – |
| Q3 2022 | $66,000 | -31.2% | 53,007 | +10.9% | 0.00% | – |
| Q2 2022 | $96,000 | +14.3% | 47,800 | +43.0% | 0.00% | – |
| Q1 2022 | $84,000 | -5.6% | 33,423 | +39.8% | 0.00% | – |
| Q4 2021 | $89,000 | +93.5% | 23,900 | +109.6% | 0.00% | – |
| Q3 2021 | $46,000 | -56.2% | 11,400 | -51.8% | 0.00% | – |
| Q2 2021 | $105,000 | -41.0% | 23,627 | +21.6% | 0.00% | – |
| Q1 2021 | $178,000 | -15.2% | 19,425 | -6.0% | 0.00% | – |
| Q4 2020 | $210,000 | +452.6% | 20,660 | +127.0% | 0.00% | – |
| Q3 2020 | $38,000 | -7.3% | 9,100 | +56.9% | 0.00% | – |
| Q2 2020 | $41,000 | – | 5,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 419,942 | $1,869,000 | 0.98% |
| Manatuck Hill Partners, LLC | 570,500 | $2,539,000 | 0.77% |
| Corriente Advisors, LLC | 203,641 | $906,000 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 275,000 | $1,224,000 | 0.40% |
| Ikarian Capital, LLC | 415,000 | $1,847,000 | 0.15% |
| COOPERMAN LEON G | 50,000 | $223,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 46,562 | $207,000 | 0.01% |
| Trexquant Investment LP | 17,019 | $76,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 30,511 | $136,000 | 0.00% |
| MARSHALL WACE, LLP | 155,662 | $693,000 | 0.00% |